These followed two deals late last week – on Thursday GSK made an $85 million licensing agreement with Surface Oncology for an early-stage antibody asset, which adds a natural killer cell ...

Walmsley said there is a lot of data expected in 2020. Walmsley said in the interview that the next year could see “at least six approvals of new medicines or new indications”. GSK is asking ...

British drugmaker GSK came to federal prosecutors in New York, bearing intel from employees' conversations that rival Pfizer allegedly delayed the 2020 release of its COVID shot study results ...

The report said on Wednesday GSK’s former head of vaccine development ... Pfizer delayed announcing its COVID shot’s success in 2020 until after that year’s election AFP via Getty Images ...

Federal prosecutors in Manhattan are probing a claim by GSK that Pfizer delayed announcing its COVID shot's success in 2020 until after that year's election, the Wall Street Journal reported, citing ...

British drugmaker GSK told Manhattan ... shot's success in 2020 until after that year's election, the Wall Street Journal reported, citing people familiar with the matter. The report said on ...

The GlaxoSmithKline Capital PLC-Bond was issued on the 5/12/2020 with a volume of 750 M. GBP. Indices Commodities Currencies Stocks ...

("GSK" or the "Company") (NYSE: GSK) American Depositary Receipts ("ADRs") between February 5, 2020, and August 14 ... the Deutsche Bank report stated that the total liability could be between $5 ...